FLR
48
5
MCO
52
2
PM
47
2
DOV
63
2
ROK
60
5
STX
66
2
WMB
58
3
PG
38
3
ZION
60
4
MTCH
68
9
GM
60
2
NFLX
40
4
TDC
62
-5
UPS
63
5
PH
63
4
STI
4
3
VRSK
12
2
PFG
58
6
PLD
58
3
TGT
53
3
FLR
48
5
MCO
52
2
PM
47
2
DOV
63
2
ROK
60
5
STX
66
2
WMB
58
3
PG
38
3
ZION
60
4
MTCH
68
9
GM
60
2
NFLX
40
4
TDC
62
-5
UPS
63
5
PH
63
4
STI
4
3
VRSK
12
2
PFG
58
6
PLD
58
3
TGT
53
3
Financhill
Back

Indivior Pharmaceuticals, Inc. 10K Form

Buy
76

INDV
Indivior Pharmaceuticals, Inc.

Last Price:
$33.89
Seasonality Move:
4.05%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive INDV News And Ratings

See the #1 stock for the next 7 days that we like better than INDV

INDV Financial Statistics

Sales & Book Value

Annual Sales: $1.2B
Cash Flow: $-62.4M
Price / Cash Flow: 32.04
Annual Sales: $-1.66
Price / Book: 238.64

Profitability

EPS (TTM): 1.00450
Net Income (TTM): $127M
Gross Margin: $998M
Return on Equity: 14.29%
Return on Assets: 9.03%

Indivior Pharmaceuticals, Inc. Earnings Forecast

Key Indivior Pharmaceuticals, Inc. Financial Ratios

  • The Gross Profit Margin over the past 14 years for INDV is 84.01%.
  • The Selling, General & Administrative Expenses for INDV have been equal to 52.02% of Gross Profit Margin.
  • The Research & Development expenses have been 9.01% of Revenue.
  • The Interest Expense is 2,050.00% of Operating Income.
  • The Net Earning history of INDV is 0.17% of Total Revenues.
  • Per Share Earnings over the last 14 years have been positive in 4 years.

Indivior Pharmaceuticals, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: INDV
Website: indivior.com

Debt

Debt-to-Equity Ratio: -1.72
Current Ratio: 0.95
Quick Ratio: 0.73

Price-to-Earnings

Trailing P/E Ratio: 2259.33
Forward P/E Ratio: 10.23

INDV Technical Analysis vs Fundamental Analysis

Buy
76
Indivior Pharmaceuticals, Inc. (INDV) is a Buy

Is Indivior Pharmaceuticals, Inc. a Buy or a Sell?